Published phase III trials comparing prostate‐only EBRT and WP EBRT with <70 Gy showed a marginally significant increase in late gastrointestinal grade ≥3 toxicity in WP EBRT groups. 17 , 18 , 19 , 20 IMRT could realize dose escalation to the prostate without increasing the dose to normal tissue in a WP irradiation setting.
← all excerpts
Ten-year outcomes of whole-pelvic intensity-modulated radiation therapy for prostate cancer with regional lymph node metastasis.
1
—
—